Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Oclaro, Inc. (OCLR): Soros Fund Management’s Latest Acquisition and Other New Positions

Page 1 of 2

George SorosSoros Fund Management has opened a new position in Oclaro, Inc. (NASDAQ:OCLR). According to the 13G Form filed with the U.S. Securities and Exchange Commission, the investment firm’s stake amounts to 12.05 million common shares, representing 9.95% of the company’s outstanding stock. In its last 13F filing, Mr. Soros’ fund also disclosed new stakes in LyondellBasell Industries NV (NYSE:LYB), Endo International plc (NASDAQ:ENDP), LendingClub Corp (NYSE:LC), and Allergan, Inc. (NYSE:AGN).

George Soros

Soros Fund Management was launched in 1969 by George Soros, the 35th richest man on the planet according to Forbes. In addition to boasting an estimated net worth of $14.2 billion, Mr. Soros founded one of the most successful and profitable hedge funds in the U.S., which delivered on average 20% in annual returns over a 40-year period. In 1992, Soros became known as “the Man Who Broke the Bank of England”, when he made $1 billion by betting against the British Pound. According to its last 13F filing, his fund’s equity portfolio is highly diversified and has a market value of $9.16 billion, down from $13.40 billion last quarter.

Soros Fund Management recently disclosed a new holding in Oclaro, Inc. (NASDAQ:OCLR), whose shares have lost around 9.5% year-to-date. Following this transaction, the hedge fund has become the company’s largest shareholder among the funds we track, thus taking a very bullish stance towards the undervalued stock. Despite volatile share prices, the stock backed by Mr. Soros reported better-than-expected earnings for the second quarter of fiscal year 2015. Although it posted a loss of $0.11 per share, that beat the average earnings consensus estimate of -$0.13 by $0.02. Although Oclaro, Inc. (NASDAQ:OCLR) also reported higher revenue than previously anticipated and now has the backing of George Soros, analysts at Zacks remain neutral regarding the company.

LyondellBasell Industries NV (NYSE:LYB) was one of the new positions disclosed by Soros Fund Management in its last 13F filing and is also one of the firm’s top picks. The position amounts to 2.83 million shares and accounts for 2.46% of the fund’s equity portfolio. Furthermore, the company is also backed by David E. Shaw’s D.E. Shaw, which owns 9.69 million shares, following a 43% increase to its exposure last quarter. Andreas Halvorsen’s Viking Global was also betting on LyondellBasell Industries NV (NYSE:LYB), disclosing a position of 4.04 million shares last quarter. Investing in this stock has proven to be wise so far, as share prices have already gained 15% year-to-date.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!